Infectious diseases, imposing density-dependent mortality on MHC/HLA variation, can account for balancing selection and MHC/HLA polymorphism
Green
The human MHC transplantation loci (HLA-A, -B, -C, -DPB1, -DQB1, -DRB1) are the most polymorphic in the human genome. It is generally accepted this polymorphism reflects a role in presenting pathogen-derived peptide to the adaptive immune system. Proposed mechanisms for the polymorphism such as negative frequency-dependent selection (NFDS) and heterozygote advantage (HA) focus on HLA alleles, not haplotypes. Here, we propose a model for the polymorphism in which infectious diseases impose independent density-dependent regulation on HLA haplotypes. More specifically, a complex pathogen environment drives extensive host polymorphism through a guild of HLA haplotypes that are specialised and show incomplete peptide recognition. Separation of haplotype guilds is maintained by limiting similarity. The outcome is a wide and stable range of haplotype densities at steady-state in which effective Fisher fitnesses are zero. Densities, and therefore frequencies, emerge theoretically as alternative measures of fitness. A catalogue of ranked frequencies is therefore one of ranked fitnesses. The model is supported by data from a range of sources including a Caucasian HLA dataset compiled by the US National Marrow Donor Program (NMDP). These provide evidence of positive selection on the top 350-2000 5-locus HLA haplotypes taken from an overall NMDP sample set of 10E5. High-fitness haplotypes drive the selection of 137 high-frequency alleles spread across the 5 HLA loci under consideration. These alleles demonstrate positive epistasis and pleiotropy in the formation of haplotypes. Allelic pleiotropy creates a network of highly inter-related HLA haplotypes that account for 97% of the census sample. We suggest this network has properties of a quasi-species and is itself under selection. We also suggest this is the origin of balancing selection in the HLA system.
academic
Infectious diseases, imposing density-dependent mortality on MHC/HLA variation, can account for balancing selection and MHC/HLA polymorphism
The human major histocompatibility complex (MHC) transplantation loci (HLA-A, -B, -C, -DPB1, -DQB1, -DRB1) represent the most polymorphic regions in the human genome. This polymorphism is widely believed to reflect their role in presenting pathogen-derived peptides to the adaptive immune system. Current proposed mechanisms for polymorphism, such as negative frequency-dependent selection (NFDS) and heterozygote advantage (HA), primarily focus on HLA alleles rather than haplotypes. This study proposes a novel model suggesting that infectious diseases impose independent density-dependent regulation on HLA haplotypes. Specifically, the complex pathogenic environment drives extensive host polymorphism through specialized HLA haplotype populations exhibiting incomplete peptide recognition. Segregation between haplotype populations is maintained through limiting similarity. The result is the production of extensive and stable haplotype density ranges at steady state, where effective Fisher fitness equals zero. Density and frequency theoretically become alternative measures of fitness. Analysis based on the National Marrow Donor Program (NMDP) Caucasian HLA dataset supports this model, providing evidence for positive selection of 350-2000 top 5-locus HLA haplotypes. High-fitness haplotypes drive selection of 137 high-frequency alleles. These alleles exhibit positive epistasis and pleiotropy in haplotype formation, creating a highly interconnected HLA haplotype network accounting for 97% of the sample total.
This study proposes an innovative theoretical framework interpreting HLA polymorphism as resulting from density-dependent selection imposed by pathogens. Through large-scale data analysis, the author discovers that the HLA system forms a highly interconnected network composed of 137 core alleles, maintaining stable polymorphism through positive epistasis and pleiotropy. This finding not only provides new perspectives for understanding MHC evolution but also establishes a theoretical foundation for related medical applications.